Short-term outcomes of entecavir versus tenofovir treatment for HBV-associated acute-on-chronic liver failure: a retrospective cohort study. // iLIVER. – URL: https://www.sciencedirect.com/science/article/pii/S2772947826000721?dgcid=rss_sd_all
Short-term outcomes of entecavir versus tenofovir treatment for HBV-associated acute-on-chronic liver failure: a retrospective cohort study. iLIVER. https://www.sciencedirect.com/science/article/pii/S2772947826000721?dgcid=rss_sd_all
“Short-term outcomes of entecavir versus tenofovir treatment for HBV-associated acute-on-chronic liver failure: a retrospective cohort study.” iLIVER.
@article{article103478,
title = {Short-term outcomes of entecavir versus tenofovir treatment for HBV-associated acute-on-chronic liver failure: a retrospective cohort study},
journal = {iLIVER},
url = {https://www.sciencedirect.com/science/article/pii/S2772947826000721?dgcid=rss_sd_all}
}